Please enable JavaScript to continue using this application.

Compare $NBP vs $ORGO | Chartloom

Compare

$NBP vs $ORGO

NovaBridge Biosciences · Organogenesis Holdings Inc

NBP

NovaBridge Biosciences

ORGO

Organogenesis Holdings Inc

Compare $NBP vs $ORGO

Comparing NovaBridge Biosciences and Organogenesis Holdings Inc

NBPNovaBridge Biosciences

ORGOOrganogenesis Holdings Inc

NBPNovaBridge Biosciences

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-72.5%

FCF yield

-33.9%

ORGOOrganogenesis Holdings Inc

Market cap

$166M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.74x

Rev growth (TTM)

6.5%

YTD performance

-72.2%

52W performance

-68.8%

FCF yield

12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NBP

ORGO

Detailed metrics comparison

NBP

NovaBridge Biosciences

ORGO

Organogenesis Holdings Inc

Market Cap

NBP$161M

ORGO$166M

Enterprise Value

NBP$-30M

ORGO$132M

Price

NBP$1.40

ORGO$1.29

P/E Ratio

NBPN/A

ORGON/A

P/S Ratio

NBP3.29x

ORGO0.36x

EV/Sales

NBP0.00x

ORGO0.29x

EV/EBITDA

NBP0.00x

ORGO7.37x

P/B Ratio

NBP0.77x

ORGO0.59x

P/FCF Ratio

NBPN/A

ORGO7.96x

EV/FCF

NBP0.55x

ORGO6.31x

PEG Ratio

NBPN/A

ORGON/A

Forward P/E (NTM)

NBPN/A

ORGON/A

Forward P/S (NTM)

NBPN/A

ORGO0.74x

Revenue (TTM)

NBP$0

ORGO$457M

Revenue Growth (YoY)

NBPN/A

ORGO6.5%

Forward Rev Growth

NBP419.8%

ORGO37.6%

Gross Margin (TTM)

NBP100.0%

ORGO70.4%

Operating Margin (TTM)

NBP0.0%

ORGO0.0%

EBITDA Margin (TTM)

NBP0.0%

ORGO-2.0%

Net Margin (TTM)

NBP0.0%

ORGO-23.1%

FCF Margin (TTM)

NBPN/A

ORGO4.6%

Net Income (TTM)

NBP$-43M

ORGO$-106M

FCF (TTM)

NBP$-55M

ORGO$21M

EPS (TTM)

NBP$0.00

ORGO-$0.82

ROE (TTM)

NBP-2091.0%

ORGO-2260.0%

ROA (TTM)

NBP-1941.0%

ORGO-1654.0%

ROIC (TTM)

NBP-2091.0%

ORGO-2187.0%

Cash

NBP$191M

ORGO$46M

Debt

NBP$0

ORGO$12M

Net Cash/Debt

NBP$191M

ORGO$34M

Current Ratio (TTM)

NBP7.64x

ORGO3.52x

Quick Ratio (TTM)

NBP7.60x

ORGO2.66x

Debt/Equity (TTM)

NBP0.00x

ORGO0.04x

Debt/Assets (TTM)

NBP0.0%

ORGO0.0%

Interest Coverage (TTM)

NBPN/A

ORGON/A

Net Debt/EBITDA (TTM)

NBP0.00x

ORGO0.00x

Beta

NBP1.69

ORGO1.44

52W Performance

NBP-72.5%

ORGO-68.8%

YTD Performance

NBP-67.3%

ORGO-72.2%

% from 52W High

NBP-79.5%

ORGO-81.8%

% from 52W Low

NBP6.5%

ORGO3.2%

Asset Turnover (TTM)

NBP0.11x

ORGO0.90x

FCF Yield (TTM)

NBP-33.9%

ORGO12.6%

Earnings Yield (TTM)

NBP-26.8%

ORGO-63.8%

Dividend Yield (TTM)

NBPN/A

ORGON/A

Rule of 40

NBP0.0

ORGO11.1

EV/GP/RG

NBPN/A

ORGO0.01

Ticker research

View NBP research View ORGO research

Metric	NBP NovaBridge Biosciences	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$161M	$166M
Enterprise Value	$-30M	$132M
Price	$1.40	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.77x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	0.55x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	419.8%	37.6%
Profitability
Gross Margin (TTM)	100.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-43M	$-106M
FCF (TTM)	$-55M	$21M
EPS (TTM)	$0.00	-$0.82
ROE (TTM)	-2091.0%	-2260.0%
ROA (TTM)	-1941.0%	-1654.0%
ROIC (TTM)	-2091.0%	-2187.0%
Financial Health
Cash	$191M	$46M
Debt	$0	$12M
Net Cash/Debt	$191M	$34M
Current Ratio (TTM)	7.64x	3.52x
Quick Ratio (TTM)	7.60x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.44
52W Performance	-72.5%	-68.8%
YTD Performance	-67.3%	-72.2%
% from 52W High	-79.5%	-81.8%
% from 52W Low	6.5%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.90x
FCF Yield (TTM)	-33.9%	12.6%
Earnings Yield (TTM)	-26.8%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View NBP research	View ORGO research

Valuation

P/S Ratio

ORGO

0.36x

NBP

3.29x

EV/FCF

NBP

0.55x

ORGO

6.31x

Growth & revenue

Revenue Growth TTM

ORGO

6.5%

Forward Revenue Growth

NBP

419.8%

ORGO

37.6%

Profitability & performance

Gross Margin

NBP

100.0%

ORGO

70.4%

ROE

NBP

-2091.0%

ORGO

-2260.0%

FCF Yield %

ORGO

12.6%

NBP

-33.9%

52-Week Performance

ORGO

-68.8%

NBP

-72.5%

Detailed metrics comparison

NBP

NovaBridge Biosciences

ORGO

Organogenesis Holdings Inc

Market Cap

NBP$161M

ORGO$166M

Enterprise Value

NBP$-30M

ORGO$132M

Price

NBP$1.40

ORGO$1.29

P/E Ratio

NBPN/A

ORGON/A

P/S Ratio

NBP3.29x

ORGO0.36x

EV/Sales

NBP0.00x

ORGO0.29x

EV/EBITDA

NBP0.00x

ORGO7.37x

P/B Ratio

NBP0.77x

ORGO0.59x

P/FCF Ratio

NBPN/A

ORGO7.96x

EV/FCF

NBP0.55x

ORGO6.31x

PEG Ratio

NBPN/A

ORGON/A

Forward P/E (NTM)

NBPN/A

ORGON/A

Forward P/S (NTM)

NBPN/A

ORGO0.74x

Revenue (TTM)

NBP$0

ORGO$457M

Revenue Growth (YoY)

NBPN/A

ORGO6.5%

Forward Rev Growth

NBP419.8%

ORGO37.6%

Gross Margin (TTM)

NBP100.0%

ORGO70.4%

Operating Margin (TTM)

NBP0.0%

ORGO0.0%

EBITDA Margin (TTM)

NBP0.0%

ORGO-2.0%

Net Margin (TTM)

NBP0.0%

ORGO-23.1%

FCF Margin (TTM)

NBPN/A

ORGO4.6%

Net Income (TTM)

NBP$-43M

ORGO$-106M

FCF (TTM)

NBP$-55M

ORGO$21M

EPS (TTM)

NBP$0.00

ORGO-$0.82

ROE (TTM)

NBP-2091.0%

ORGO-2260.0%

ROA (TTM)

NBP-1941.0%

ORGO-1654.0%

ROIC (TTM)

NBP-2091.0%

ORGO-2187.0%

Cash

NBP$191M

ORGO$46M

Debt

NBP$0

ORGO$12M

Net Cash/Debt

NBP$191M

ORGO$34M

Current Ratio (TTM)

NBP7.64x

ORGO3.52x

Quick Ratio (TTM)

NBP7.60x

ORGO2.66x

Debt/Equity (TTM)

NBP0.00x

ORGO0.04x

Debt/Assets (TTM)

NBP0.0%

ORGO0.0%

Interest Coverage (TTM)

NBPN/A

ORGON/A

Net Debt/EBITDA (TTM)

NBP0.00x

ORGO0.00x

Beta

NBP1.69

ORGO1.44

52W Performance

NBP-72.5%

ORGO-68.8%

YTD Performance

NBP-67.3%

ORGO-72.2%

% from 52W High

NBP-79.5%

ORGO-81.8%

% from 52W Low

NBP6.5%

ORGO3.2%

Asset Turnover (TTM)

NBP0.11x

ORGO0.90x

FCF Yield (TTM)

NBP-33.9%

ORGO12.6%

Earnings Yield (TTM)

NBP-26.8%

ORGO-63.8%

Dividend Yield (TTM)

NBPN/A

ORGON/A

Rule of 40

NBP0.0

ORGO11.1

EV/GP/RG

NBPN/A

ORGO0.01

Ticker research

View NBP research View ORGO research

Metric	NBP NovaBridge Biosciences	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$161M	$166M
Enterprise Value	$-30M	$132M
Price	$1.40	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.77x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	0.55x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	419.8%	37.6%
Profitability
Gross Margin (TTM)	100.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-43M	$-106M
FCF (TTM)	$-55M	$21M
EPS (TTM)	$0.00	-$0.82
ROE (TTM)	-2091.0%	-2260.0%
ROA (TTM)	-1941.0%	-1654.0%
ROIC (TTM)	-2091.0%	-2187.0%
Financial Health
Cash	$191M	$46M
Debt	$0	$12M
Net Cash/Debt	$191M	$34M
Current Ratio (TTM)	7.64x	3.52x
Quick Ratio (TTM)	7.60x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.44
52W Performance	-72.5%	-68.8%
YTD Performance	-67.3%	-72.2%
% from 52W High	-79.5%	-81.8%
% from 52W Low	6.5%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.90x
FCF Yield (TTM)	-33.9%	12.6%
Earnings Yield (TTM)	-26.8%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View NBP research	View ORGO research